This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Leukemia Research Foundation names Dr. Tulio Rodriguez 'Hero of Hope'

October 3rd, 2012

The Leukemia Research Foundation has named Loyola University Medical Center oncologist Dr. Tulio Rodriguez one of its "Heroes for Hope."

The foundation cited Rodriguez for participating numerous times in the foundation's Patient Education Series. Rodriguez also has been a panelist and presenter at the foundation's Town Hall Meeting, Town Hall Meeting in Spanish and Treatment Options for Blood Cancer Patients Conference.

September was National Blood Cancer Awareness Month. Each day during the month, the foundation designated a new Hero. Rodriguez's designation was announced Sept. 27 on the foundation's Facebook page www.facebook.com/leukemiaresearch

"Our heroes are people, companies and partnering organizations that help us in the fight to cure blood cancers," said Leukemia Research Foundation spokesman Carl F. Alston.

Rodriguez is an associate professor in the Department of Medicine, Division of Hematology/Oncology of Loyola University Chicago Stritch School of Medicine. His special interests include blood disorders, leukemia, monoclonal gammopathies, multiple myeloma, non-Hodgkins lymphoma and stem cell/bone marrow transplant.

The Leukemia Research Foundation funds medical research into the causes and cures of blood cancers, provides patient financial assistance and offers educational and emotional support programs.

Provided by Loyola University Health System

Citation: Leukemia Research Foundation names Dr. Tulio Rodriguez 'Hero of Hope' (2012, October 3) retrieved 4 August 2026 from https://sciencex.com/wire-news/110741838/leukemia-research-foundation-names-dr-tulio-rodriguez-hero-of-ho.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.